Angus Kennedy - Concepedia

Author

Angus Kennedy

Also Known As

A Kennedy, A M Kennedy, A. KENNEDY, A. Kennedy, A. M KENNEDY, A. M. KENNEDY, A. M. Kennedy, A.M Kennedy, A.M. KENNEDY, A.M. Kennedy

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

University College London Hammersmith Hospital National Hospital for Neurology and Neurosurgery Imperial College London Chelsea and Westminster Hospital

About

Angus Kennedy is an author at University College London specializing in medicine, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	3.3K
2	Health Sciences	6	6	1.1K
3	Social Sciences	3	3	221
4	Engineering	1	1	11
5	Anesthesia	1	1	38

Angus Kennedy

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
In-vivo measurement of activated microglia in dementia Annachiara Cagnin, David J. Brooks, Angus Kennedy, The Lancet Alzheimer's DiseaseActivated MicrogliaDementiaMedicineBrain-immune Interaction	2001	1.1K
Presymptomatic hippocampal atrophy in Alzheimer's disease Nick C. Fox, Elizabeth K. Warrington, Peter A. Freeborough, Brain Presymptomatic Hippocampal AtrophyNeuropsychologyAlzheimer's DiseasePsychiatryMedicine	1996	650
Conversion of amyloid positive and negative MCI to AD over 3 years Aren Okello, J. Koivunen, Paul Edison, Neurology	2009	513
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study Paul Edison, Hilary Archer, Alexander Gerhard, Neurobiology of Disease Alzheimer's DiseaseMedicineDementiaBrain-immune InteractionNeurology	2008	509
Amyloid, hypometabolism, and cognition in Alzheimer disease Paul Edison, Hilary Archer, Rainer Hinz, Neurology	2006	506
The structure of the presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families Robert Clark, M. Hutton, M. Fuldner, Nature Genetics Allelic VariantGenetic DisorderGeneticsNovel MutationsMolecular Biology	1995	470
Microglial activation and amyloid deposition in mild cognitive impairment Aren Okello, Paul Edison, Hilary Archer, Neurology	2009	356
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial John Collinge, Michele Gorham, Fleur Hudson, The Lancet Neurology	2009	259
Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease Angus Kennedy, R. S. J. Frackowiak, Sarah Newman, Neuroscience Letters Positron Emission TomographyAlzheimer's DiseaseHealth SciencesDementiaVascular Dementia	1995	250
Alzheimer's patients engage an alternative network during a memory task Jérémie Pariente, Susanna Cole, Richard N. Henson, Annals of Neurology	2005	160

Page 1